» Articles » PMID: 11880308

Angiogenic Factors and Alveolar Vasculature: Development and Alterations by Injury in Very Premature Baboons

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Proper formation of the pulmonary microvasculature is essential for normal lung development and gas exchange. Lung microvascular development may be disrupted by chronic injury of developing lungs in clinical diseases such as bronchopulmonary dysplasia. We examined microvascular development, angiogenic growth factors, and endothelial cell receptors in a fetal baboon model of chronic lung disease (CLD). In the last third of gestation, the endothelial cell marker platelet endothelial cell adhesion molecule (PECAM)-1 increased 7.5-fold, and capillaries immunostained for PECAM-1 changed from a central location in airspace septa to a subepithelial location. In premature animals delivered at 67% of term and supported with oxygen and ventilation for 14 days, PECAM-1 protein and capillary density did not increase, suggesting failure to expand the capillary network. The capillaries of the CLD animals were dysmorphic and not subepithelial. The angiogenic growth factor vascular endothelial growth factor (VEGF) and its receptor fms-like tyrosine kinase receptor (Flt-1) were significantly decreased in CLD. Angiopoietin-1, another angiogenic growth factor, and its receptor tyrosine kinase with immunoglobulin and epidermal growth factor homology domains were not significantly changed. These data suggest that CLD impairs lung microvascular development and that a possible mechanism is disruption of VEGF and Flt-1 expression.

Citing Articles

Amphiregulin Exerts Proangiogenic Effects in Developing Murine Lungs.

Thapa S, Shankar N, Shrestha A, Civunigunta M, Gaikwad A, Shivanna B Antioxidants (Basel). 2024; 13(1).

PMID: 38247502 PMC: 10812697. DOI: 10.3390/antiox13010078.


Atrial septal defect closure is associated with improved clinical status in patients ≤ 10 kg with bronchopulmonary dysplasia.

Webb M, Guaman M, Sexson Tejtel S, Cambronero N, Coleman R, Chartan C Pulm Circ. 2023; 13(4):e12299.

PMID: 37868716 PMC: 10588322. DOI: 10.1002/pul2.12299.


Bronchopulmonary dysplasia - associated pulmonary hypertension: An updated review.

El-Saie A, Varghese N, Webb M, Villafranco N, Gandhi B, Guaman M Semin Perinatol. 2023; 47(6):151817.

PMID: 37783579 PMC: 10843293. DOI: 10.1016/j.semperi.2023.151817.


New insights into the natural history of bronchopulmonary dysplasia from proteomics and multiplexed immunohistochemistry.

Dylag A, Misra R, Bandyopadhyay G, Poole C, Huyck H, Jehrio M Am J Physiol Lung Cell Mol Physiol. 2023; 325(4):L419-L433.

PMID: 37489262 PMC: 10642360. DOI: 10.1152/ajplung.00130.2023.


Biomarkers of lung alveolarization and microvascular maturation in response to intermittent hypoxia and/or early antioxidant/fish oil supplementation in neonatal rats.

Marcelino M, Cai C, Wadowski S, Aranda J, Beharry K Pediatr Pulmonol. 2023; 58(8):2352-2363.

PMID: 37265429 PMC: 10463793. DOI: 10.1002/ppul.26495.